How many rounds has the National Family Health Survey successfully completed?
Iron and folic acid supplementation to children is a form of
What is the recommended number of doses for the treatment of Vitamin A deficiency?
Trace element constitutes what percentage of body weight?
A 6-month-old child presents with respiratory distress including chest indrawing and is unable to drink milk. As per IMNCI guidelines, how will this child be classified?
What was the fourth Millennium Development Goal?
The growth monitoring of a child at an Anganwadi is primarily intended for what purpose?
Which of the following timelines would be included in the perinatal period?
The Pearl Index is a measure of:
Under the National Maternity Benefit scheme, what is the financial assistance given per birth for the first two births to all pregnant women who attain 19 years of age and belong to BPL households?
Explanation: **Explanation:** The National Family Health Survey (NFHS) is a large-scale, multi-round survey conducted in a representative sample of households throughout India. It provides high-quality data on health and family welfare, which is essential for policy-making and monitoring program outcomes. **Why Option C is Correct:** At the time this specific question was framed in historical NEET-PG/medical entrance contexts, the NFHS had successfully completed **three rounds** (NFHS-1 in 1992-93, NFHS-2 in 1998-99, and NFHS-3 in 2005-06). These rounds established the baseline for maternal and child health indicators in India. **Why Other Options are Incorrect:** * **Options A & B:** These represent the earlier stages of the survey's history. By the mid-2000s, the survey had already surpassed these milestones. * **Option D:** While NFHS-4 (2015-16) and NFHS-5 (2019-21) have since been completed, in the context of the standard "classic" question often repeated in older question banks, "Three rounds" was the landmark answer. **High-Yield Clinical Pearls for NEET-PG:** * **Nodal Agency:** The **International Institute for Population Sciences (IIPS)**, Mumbai, is the nodal agency for all NFHS rounds. * **Funding:** Primarily funded by USAID with supplementary support from UNICEF. * **NFHS-5 (Latest Data):** It is the first round to provide district-level estimates for many indicators. Key findings include a **Total Fertility Rate (TFR)** of **2.0**, which is below the replacement level (2.1). * **Scope:** NFHS covers critical indicators like infant mortality (IMR), maternal mortality (MMR), contraceptive prevalence, nutrition (stunting/wasting), and immunization coverage.
Explanation: This question tests your understanding of the **Levels of Prevention** and **Modes of Intervention**, a high-yield topic in Community Medicine. ### Why "Specific Protection" is Correct **Specific Protection** is a mode of intervention under **Primary Prevention**. It involves measures taken to prevent the occurrence of a specific disease before its onset. Since Iron and Folic Acid (IFA) supplementation is a targeted intervention aimed specifically at preventing nutritional anemia, it falls under this category. Other examples include immunizations, use of helmets, and chemoprophylaxis. ### Why Other Options are Incorrect * **Health Promotion:** This also falls under Primary Prevention but is non-specific. It aims at strengthening the host through better lifestyle, nutrition, and environment (e.g., health education, environmental sanitation). IFA is a specific nutrient intervention, not a general lifestyle improvement. * **Primordial Prevention:** This focuses on preventing the emergence of risk factors (e.g., discouraging children from starting smoking). Since the risk factor (nutritional deficiency) already exists in the population, IFA is primary, not primordial. * **Secondary Prevention:** This involves "early diagnosis and prompt treatment" (e.g., screening tests). Supplementation is a preventive measure, not a diagnostic or curative one for an established case. ### NEET-PG High-Yield Pearls * **Anemia Mukt Bharat (AMB) Strategy:** * **Children (6–59 months):** 20 mg Iron + 100 mcg Folic acid (Bi-weekly syrup). * **Children (5–9 years):** 45 mg Iron + 400 mcg Folic acid (Weekly pink tablet). * **Adolescents (10–19 years):** 60 mg Iron + 400 mcg Folic acid (Weekly blue tablet). * **Concept Check:** If a patient *already has* anemia and you give Iron, it is **Tertiary Prevention** (disability limitation) or **Secondary Prevention** (treatment), but *supplementation* to a population is always **Specific Protection**.
Explanation: **Explanation:** The correct answer is **3 doses**. This recommendation follows the World Health Organization (WHO) and National Guidelines for the treatment of clinical Vitamin A deficiency (Xerophthalmia) in children. **Why 3 doses is correct:** When a child presents with clinical signs of Vitamin A deficiency (such as Bitot's spots, corneal xerosis, or keratomalacia), a specific therapeutic schedule is required to replenish liver stores and prevent permanent blindness. The schedule is: * **1st Dose:** Immediately on diagnosis. * **2nd Dose:** The following day (Day 2). * **3rd Dose:** At least two weeks (14 days) later. **Why other options are incorrect:** * **Option A (1 dose):** A single dose is insufficient to build adequate long-term liver reserves in a clinically deficient child. * **Option B (2 doses):** While the first two doses provide immediate treatment, the third dose is crucial for sustained recovery and preventing relapse. * **Option D (4 doses):** There is no standard clinical protocol requiring four doses for the initial treatment of xerophthalmia. **High-Yield Clinical Pearls for NEET-PG:** * **Dosage by Age:** * <6 months: 50,000 IU per dose. * 6–11 months: 100,000 IU per dose. * >12 months: 200,000 IU per dose. * **Prophylaxis vs. Treatment:** Do not confuse *treatment* (3 doses) with *prophylaxis* (9 doses total under the National Vitamin A Prophylaxis Programme, given every 6 months starting from age 9 months to 5 years). * **Measles Connection:** Children with measles should also receive two doses (Day 1 and Day 2) to prevent complications, even in the absence of clinical eye signs.
Explanation: **Explanation:** The human body is composed of various elements categorized based on their concentration and requirement. **Trace elements** (also known as micro-minerals) are defined as minerals required by the body in very small amounts—typically less than 100 mg/day. Collectively, these elements constitute approximately **0.01% of the total body weight.** **1. Why 0.01% is Correct:** The bulk of human body weight (approx. 96-99%) is made up of major elements like Oxygen, Carbon, Hydrogen, Nitrogen, Calcium, and Phosphorus. Trace elements—which include Iron, Iodine, Zinc, Copper, Fluorine, Selenium, and Manganese—perform vital regulatory and catalytic functions but exist in minute quantities, making up the remaining fraction of roughly 0.01%. **2. Analysis of Incorrect Options:** * **0.001% (Option A):** This is too low; while individual ultra-trace elements (like Selenium) may exist at this level, the collective group is more substantial. * **0.1% (Option B):** This value is ten times higher than the actual concentration of trace elements. * **1% (Option D):** This is closer to the percentage of "Macro-minerals" (like Magnesium or Potassium) rather than trace elements. **High-Yield Clinical Pearls for NEET-PG:** * **Most Abundant Trace Element:** Iron (Fe) is the most abundant trace element in the body. * **Essential vs. Non-essential:** Essential trace elements are those whose deficiency results in an impairment of a relevant biological function (e.g., Iodine for thyroid hormone synthesis). * **Fluorine:** Often called a "two-edged sword" because it prevents dental caries at 0.5–0.8 mg/L but causes fluorosis if >1.5 mg/L. * **Zinc:** Crucial for wound healing and as a cofactor for over 300 enzymes; its deficiency is linked to Acrodermatitis enteropathica.
Explanation: ### Explanation This question tests the classification of acute respiratory infections (ARI) based on the **Integrated Management of Neonatal and Childhood Illness (IMNCI)** guidelines for children aged 2 months to 5 years. **1. Why "Very Severe Pneumonia" is correct:** Under IMNCI, the classification is based on a hierarchy of clinical severity. The presence of any **General Danger Sign** automatically upgrades the classification to the most severe category. In this case, the child is **unable to drink or breastfeed**, which is a General Danger Sign. Even though chest indrawing is present (a sign of "Severe Pneumonia"), the presence of a danger sign necessitates a classification of **Very Severe Disease/Pneumonia**. **2. Why other options are incorrect:** * **Pneumonia:** This is classified by **fast breathing** (Age 2–12 months: ≥50 bpm; 12 months–5 years: ≥40 bpm) without chest indrawing or danger signs. * **Severe Pneumonia:** This is classified by the presence of **chest indrawing** but *without* any General Danger Signs. * **Sepsis with pneumonia:** While clinically plausible, "Sepsis" is not a standard classification term for respiratory distress in the IMNCI 2 months–5 years algorithm. Sepsis is more commonly used in the "Young Infant" (0–2 months) algorithm. **3. High-Yield Clinical Pearls for NEET-PG:** * **General Danger Signs (IMNCI):** 1. Unable to drink/breastfeed, 2. Vomits everything, 3. Convulsions (during current illness), 4. Lethargic or unconscious. * **Treatment:** Very Severe Pneumonia requires the first dose of an appropriate antibiotic (e.g., IV/IM Ampicillin and Gentamicin) and **urgent referral** to a tertiary center. * **Fast Breathing Cut-offs:** * <2 months: ≥60 bpm * 2–12 months: ≥50 bpm * 1–5 years: ≥40 bpm
Explanation: **Explanation:** The **Millennium Development Goals (MDGs)** were eight international development goals established following the Millennium Summit of the United Nations in 2000, intended to be achieved by 2015. **Correct Option (D):** MDG 4 specifically aimed to **reduce child mortality**. The target was to reduce the Under-Five Mortality Rate (U5MR) by two-thirds between 1990 and 2015. This goal focused on improving child survival through immunization, nutrition, and treatment of common childhood illnesses like pneumonia and diarrhea. **Analysis of Incorrect Options:** * **Option A (MDG 5):** This goal aimed to **Improve Maternal Health**, with the specific target of reducing the Maternal Mortality Ratio (MMR) by three-quarters. * **Option B (MDG 6):** This goal focused on **Combating HIV/AIDS, Malaria, and other diseases** (such as Tuberculosis). * **Option C (MDG 7):** This goal aimed to **Ensure Environmental Sustainability**, which included targets for safe drinking water and basic sanitation. **High-Yield Facts for NEET-PG:** * **Transition to SDGs:** In 2016, MDGs were replaced by the **Sustainable Development Goals (SDGs)**, which consist of **17 goals** to be achieved by 2030. * **SDG 3:** All health-related MDGs (4, 5, and 6) are now consolidated under **SDG 3: "Ensure healthy lives and promote well-being for all at all ages."** * **Current Targets (SDG 3.2):** By 2030, the goal is to reduce Neonatal Mortality Rate (NMR) to at least **12 per 1,000 live births** and Under-5 Mortality to at least **25 per 1,000 live births**.
Explanation: **Explanation:** Growth monitoring is a core activity of the **Integrated Child Development Services (ICDS)** scheme. While it involves the physical act of weighing a child and plotting it on a growth chart (Road to Health chart), its primary objective is **action-oriented**. 1. **Why Option C is Correct:** Growth monitoring is not merely a diagnostic tool but a screening mechanism to trigger intervention. In the ICDS framework, the primary intervention following the identification of growth faltering or malnutrition is **Supplementary Nutrition (SN)**. By monitoring the growth curve, the Anganwadi Worker (AWK) identifies children who need additional caloric and protein support (e.g., Take-Home Rations or morning snacks) to prevent further deterioration and promote "catch-up" growth. 2. **Why Other Options are Incorrect:** * **Option A:** While it identifies healthy babies, the program's goal is to intervene where growth is suboptimal. * **Option B:** Diagnosis of growth retardation is a clinical process involving detailed anthropometry and medical assessment, whereas Anganwadis focus on community-level screening. * **Option D:** Estimating the extent of malnutrition is a **statistical/epidemiological** byproduct (situational analysis) rather than the primary functional purpose of the activity at the service delivery level. **High-Yield Pearls for NEET-PG:** * **The Tool:** The **WHO Growth Chart (2006)** is used. Boys' charts are Blue; Girls' charts are Pink. * **The Indicator:** Weight-for-Age is the primary indicator used in Anganwadis for rapid screening. * **The Intervention:** Under ICDS, "Severely Underweight" children receive double the rations compared to "Moderately Underweight" children. * **The "Road to Health" Chart:** The most important feature is the **direction of the curve**: * Upward: Good * Flat: Warning (Static growth) * Downward: Danger (Growth faltering)
Explanation: ### Explanation The **Perinatal Period** is a critical indicator of obstetric and neonatal care quality. According to the **World Health Organization (WHO)** and the International Classification of Diseases (ICD-10), the perinatal period commences at **22 completed weeks (154 days)** of gestation (when birth weight is normally 500g) and ends **7 completed days** after birth. However, for national health reporting and the **NEET-PG** context, the definition is often extended to include the late neonatal period to capture comprehensive mortality data. Therefore, the period from **22 weeks of gestation to 28 days after birth** is the most appropriate choice among the options provided. #### Analysis of Options: * **Option A (37th week to 28 days):** Incorrect. 37 weeks marks the beginning of a "term" pregnancy, but the perinatal period includes preterm viable fetuses starting from 22 or 28 weeks. * **Option B (19th week to 7 days):** Incorrect. 19 weeks is considered pre-viable (abortion) rather than perinatal. * **Option C (32nd week to 28 days):** Incorrect. This timeline misses the early viable window (22–31 weeks). * **Option D (Correct):** This aligns with the standard definition of viability (22 weeks) and covers the entire neonatal period (up to 28 days). #### High-Yield Clinical Pearls for NEET-PG: 1. **Perinatal Mortality Rate (PNMR):** Calculated as (Late Fetal Deaths + Early Neonatal Deaths) / (Live Births + Stillbirths) × 1000. 2. **Viability Threshold:** In India, for statistical purposes, the perinatal period is sometimes cited as starting from **28 weeks** (1000g), but the WHO standard of **22 weeks** (500g) is increasingly tested. 3. **Neonatal Period:** Divided into **Early Neonatal** (0–7 days) and **Late Neonatal** (7–28 days). 4. **Stillbirth:** Defined as fetal death after 28 weeks of gestation.
Explanation: **Explanation:** The **Pearl Index** is the standard method used in clinical trials and epidemiological studies to express the **effectiveness of a contraceptive method**. It measures the number of unintended pregnancies that occur per 100 woman-years of exposure. **Why Option A is correct:** The Pearl Index calculates the failure rate of a contraceptive. The formula is: $$Pearl\ Index = \frac{\text{Total Accidental Pregnancies} \times 1200}{\text{Total Months of Exposure (Usage)}}$$ A lower Pearl Index indicates a more effective contraceptive method. For example, the Pearl Index for Oral Contraceptive Pills (perfect use) is approximately 0.3, while for the rhythm method, it can be as high as 25. **Why other options are incorrect:** * **B. Fertility rate:** This is measured by indicators like the General Fertility Rate (GFR) or Total Fertility Rate (TFR), which track live births in a population, not contraceptive failure. * **C. Potency of disinfectants:** This is measured by the **Rideal-Walker Coefficient** or the Chick-Martin test. * **D. Couple Protection Rate (CPR):** This is a service statistics indicator that measures the percentage of eligible couples effectively protected against childbirth by one or the other approved methods of family planning. **High-Yield Clinical Pearls for NEET-PG:** * **Life Table Analysis:** This is considered superior to the Pearl Index because it calculates failure rates at specific intervals (e.g., at 6 months, 12 months) and accounts for "drop-outs." * **Most Effective Contraceptive:** Implants (e.g., Nexplanon) have the lowest Pearl Index (~0.05). * **Theoretical vs. Typical Use:** The Pearl Index varies significantly between "perfect use" (clinical trials) and "typical use" (real-world settings).
Explanation: ### Explanation **1. Why Option A is Correct:** The **National Maternity Benefit Scheme (NMBS)** was introduced in 1995 as a component of the National Social Assistance Programme (NSAP). Its primary objective was to provide social security to pregnant women from Below Poverty Line (BPL) households. Under this scheme, a one-time lump sum cash assistance of **Rs. 500** is provided to the mother for the first two live births, provided she is at least 19 years of age. The payment is ideally made 8–12 weeks prior to delivery. **2. Why Other Options are Incorrect:** * **Options B, C, and D:** These amounts do not correspond to the original NMBS guidelines. While later schemes like **Janani Suraksha Yojana (JSY)** increased financial incentives (e.g., Rs. 1,400 for rural and Rs. 700 for urban areas in Low Performing States), the specific historical mandate for NMBS remains fixed at Rs. 500 in standard public health textbooks and previous exam patterns. **3. High-Yield Clinical Pearls for NEET-PG:** * **Evolution of Schemes:** NMBS was later modified and incorporated into the **Janani Suraksha Yojana (JSY)** in April 2005 to further reduce Maternal Mortality Ratio (MMR) and Infant Mortality Rate (IMR) by promoting institutional deliveries. * **Eligibility Criteria:** For NMBS, the woman must be BPL and $\geq$ 19 years old. For JSY, the focus shifts toward institutional delivery regardless of age or number of children in Low Performing States (LPS). * **Pradhan Mantri Matru Vandana Yojana (PMMVY):** Do not confuse NMBS with PMMVY, which currently provides **Rs. 5,000** in three installments for the first live birth to compensate for wage loss. * **Key Target:** NMBS specifically targeted the "nutritional status" of the mother, whereas JSY targets "institutional delivery."
Maternal Mortality: Causes and Prevention
Practice Questions
Antenatal Care
Practice Questions
Intranatal Care
Practice Questions
Postnatal Care
Practice Questions
High-Risk Pregnancy Management
Practice Questions
Infant Mortality: Causes and Prevention
Practice Questions
Under-Five Mortality
Practice Questions
Integrated Management of Neonatal and Childhood Illness
Practice Questions
School Health Services
Practice Questions
Adolescent Health
Practice Questions
Reproductive and Child Health Programs
Practice Questions
International Maternal and Child Health Initiatives
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free